ACLX Arcellx, Inc.
Healthcare$115.07+0.02%ClosedMarket Cap: $6.73B
As of 2026-05-25
Analyst Consensus
Consensus
Hold
Target (Consensus)
$112.45
Target (Median)
$115.00
Target Range
$82.00 - $120.00
Upside from current price: -2.3%
Rating Distribution
0 Strong Buy0 Buy14 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-02-26 | Guggenheim | downgrade | Neutral | Buy |
| 2026-02-24 | Citigroup | downgrade | Neutral | Buy |
| 2026-02-24 | UBS | downgrade | Neutral | Buy |
| 2026-02-24 | Evercore ISI Group | downgrade | In Line | Outperform |
| 2026-02-24 | Truist Securities | downgrade | Hold | Buy |
| 2026-02-24 | Stifel | downgrade | Hold | Buy |
| 2026-02-24 | Leerink Partners | downgrade | Market Perform | Outperform |
| 2026-02-23 | HC Wainwright & Co. | downgrade | Neutral | Buy |
| 2026-02-23 | Baird | downgrade | Neutral | Outperform |
| 2026-02-23 | Needham | downgrade | Hold | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Thu Dec 31 | $-3.71 | $73.7M | 8 |
| Fri Dec 31 | $-1.71 | $261.7M | 8 |
| Sun Dec 31 | $0.39 | $446.2M | 8 |
| Mon Dec 31 | $3.87 | $742.7M | 6 |